Category: AHA
-
STAT+: Does coffee mix with AFib, and other new data from heart meeting
STAT+: Does coffee mix with AFib, and other new data from heart meeting This is the online version of AHA in 30 Seconds, the latest from the American Heart Association’s scientific sessions. Hello from New Orleans. Coming from Boston, running on the River Walk this morning felt balmy, not as shockingly hot and humid…
-
New AHA leader sees AI as way to address cardiology’s blind spot: women
New AHA leader sees AI as way to address cardiology’s blind spot: women NEW ORLEANS — Stacey Rosen is a cardiologist who has been coming to American Heart Association meetings for 30 years. Executive director of Northwell’s Katz Institute for Women’s Health, she is also senior vice president of Women’s Health at Northwell, a professor…
-
STAT+: Merck’s pill to reduce cholesterol on top of statins matches results from injectables
STAT+: Merck’s pill to reduce cholesterol on top of statins matches results from injectables NEW ORLEANS — A pill designed to further lower cholesterol in people already on statins but at risk of a serious cardiovascular event — their first or a recurrence — reduced LDL cholesterol by up to 60%, a new late-stage trial…
-
STAT+: Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm
STAT+: Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm NEW ORLEANS — A cholesterol-lowering injection that’s been on the market for nearly a decade has now shown its power to cut cardiovascular events in people considered at high risk but who haven’t yet suffered a heart attack or stroke. A…
-
STAT+: CRISPR-based treatment cuts cholesterol and triglycerides in early study
STAT+: CRISPR-based treatment cuts cholesterol and triglycerides in early study A CRISPR-based gene editing therapy dramatically reduced levels of low-density lipoprotein, often called “bad cholesterol,” and triglycerides in patients with heart disease, a new study found. Some researchers said that the treatment, developed by the biotech CRISPR Therapeutics and so far tested in just 15…